Convatec Group PLC (LON:CTEC)
252.80
+4.20 (1.69%)
Nov 11, 2026, 12:58 PM GMT
Convatec Group Revenue
Convatec Group had revenue of $1.23B USD in the half year ending June 30, 2026, with 10.65% growth. This brings the company's total for the last twelve months to $2.49B, up 5.75% year-over-year. In the year 2025, Convatec Group had annual revenue of $2.44B with 6.54% growth. That makes Convatec Group the 4,302nd largest company in the world by revenue and 133rd in the United Kingdom.
Revenue (ttm)
$2.49B
Revenue Growth
+5.75%
P/S Ratio
2.59
Revenue / Employee
$249.11K
Employees
10,000
Market Cap
4.94B GBP
Revenue by Geography
- US 909.00M 37.3%
- Other 905.00M 37.1%
- Denmark 456.00M 18.7%
- UK 169.00M 6.9%
Fiscal year ended Dec 31, 2025 See the full Convatec Group breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.44B | 149.80M | 6.54% |
| Dec 31, 2024 | 2.29B | 146.80M | 6.85% |
| Dec 31, 2023 | 2.14B | 69.90M | 3.37% |
| Dec 31, 2022 | 2.07B | 34.20M | 1.68% |
| Dec 31, 2021 | 2.04B | 144.00M | 7.60% |
| Dec 31, 2020 | 1.89B | 67.10M | 3.67% |
| Dec 31, 2019 | 1.83B | -4.90M | -0.27% |
| Dec 31, 2018 | 1.83B | 67.50M | 3.83% |
| Dec 31, 2017 | 1.76B | 76.30M | 4.52% |
| Dec 31, 2016 | 1.69B | 37.90M | 2.30% |
| Dec 31, 2015 | 1.65B | -83.80M | -4.83% |
| Dec 31, 2014 | 1.73B | 33.50M | 1.97% |
| Dec 31, 2013 | 1.70B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.99B |
| GSK plc | 33.54B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| Hikma Pharmaceuticals | 2.58B |
| Spire Healthcare Group | 1.58B |
| CVS Group | 712.80M |
| Genus | 658.10M |
Convatec Group News
- 20 days ago - Convatec Recognized With Two Prestigious Vizient® Supplier Excellence Awards - Business Wire
- 5 weeks ago - Convatec Survey Challenges Assumptions About Leakage in Ostomy Care - Business Wire
- 6 weeks ago - Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize - Business Wire
- 3 months ago - Convatec Group Earnings Call Transcript: H1 2026 - Transcripts
- 3 months ago - Convatec Group Quarterly report: H1 2026 - Filings
- 3 months ago - Convatec Group Slides: H1 2026 - Filings
- 3 months ago - UK's Convatec expects higher second-half margin, launches $200 million buyback - Reuters
- 5 months ago - Medical product maker Convatec warns of higher cost from Iran War - Reuters